SEGM

653 件のポスト
プロフィール画像を開きます
フォロー
SEGM
@segm_ebm
Society for Evidence-Based Gender Medicine. Promoting ethical and evidence-informed healthcare for children, adolescents & young adults. (Formerly SEGMtweets)
医療・健康United Statessegm.org2019年10月からTwitterを利用しています

SEGMさんのポスト

固定
Our recent Spotlight highlights a study from Finland, which convincingly demonstrates that suicides are uncommon in gender-dysphoric youth. The study demonstrates why youth gender transitions can’t be justified by the “suicide-prevention” argument./1
23
654
The Norwegian Healthcare Investigation Board, (NHIB/UKOM) has deemed puberty blockers, cross-sex-hormones & surgery for children & young people experimental, determining that the current “gender-affirmative” guidelines are not evidence-based and must be revised. /1
121
6,098
The Director of the Belgian Center for Evidence-Based Medicine (CEBAM) Dr. Patrik Vankrunkelsven has joined a growing list of experts who are criticizing the highly medicalized "gender-affirming" treatment approach for minors with gender dysphoria as not evidence-based. /1
画像
引用
VRT NWS
@vrtnws
Fel debat over puberteitsremmers en mannelijke/vrouwelijke hormonen: "Wat jullie doen, is een experiment op kinderen" vrtnws.be/p.mRVGnWK1E?t= #vrtnws
39
2,305
A new peer-reviewed open-access study exposes deep flaws in the Dutch studies that formed the foundation for youth gender transition. These studies should have never been used to launch the practice into mainstream medicine, conclude the authors./1
47
2,222
The Karolinska Hospital in Sweden has issued a policy statement regarding treatment of gender dysphoric minors at its pediatric gender services division. This policy ends the practice of prescribing puberty blockers and cross-sex hormones to minors <16. /1
57
1,747
返信先: さん
The UKOM report asserts that future guidelines must rely on a systematic review of evidence rather than cherry-picking studies, and that all hormonal and surgical interventions must be restricted to research settings to ensure clear protocols, safeguarding & adequate follow-up./2
4
1,438
The NHS has ended "gender-affirming care" in England for <18s, according to the newly-released draft guidance. Psychotherapy will be the first & usually only line of treatment. Puberty blockers will be confined to research settings. SEGM's analysis below:
37
1,267
The journal of the Danish Medical Association Ugeskrift for Læger has confirmed that Denmark is restricting medical transition of gender-dysphoric minors. Only 6% of the gender clinic referrals were approved for transition in 2022, down from 65% in 2018./1
28
1,251
返信先: さん
In summary, Sweden has changed direction because of a lack of evidence to support medical interventions for gender-dysphoric minors. A new emphasis has been placed on psychiatric care and psychosocial support. Hormonal interventions for minors will be highly restricted. /10
20
1,186
Do puberty blockers improve mental health? The original Dutch studies claimed so, but a replication attempt in the UK failed, finding no impact. A new peer-reviewed reanalysis of the UK data shows that up to 34% of youth actually "reliably deteriorated"./1
36
1,195
返信先: さん
The Norwegian Healthcare Investigation Board noted several worrying trends: the rapid rise of gender dysphoria in adolescents (esp. females), the high burden of mental illness (75%) & a high prevalence of neurocognitive conditions (ADHD/autism, Tourette) in the affected youth. /6
5
1,134
The National Academy of Health in France has just issued a press release regarding the care of gender-dysphoric youth. The Academy is advising psychological exploration, and cautions about the risks of pursuing hormones & surgery in youth /1.
21
1,125
返信先: さん
Under the current Norwegian guidelines, youth may receive puberty blockers at tanner stage 2, cross-sex-hormones at 16, and surgeries at 18. The report noted that these widely available interventions are irreversible, carry many risks, and rest on insufficient evidence. /4
4
1,078
返信先: さん
However, unlike Sweden, Finland and England, Norway explicitly calls out the group of young adults whose development is still ongoing and who are at risk for erroneously undertaking gender transitions. The report notes that the age of consent for sterilization in Norway is 25./8
5
1,050
返信先: さん
The report criticized Norway’s current "gender-affirmative" guidelines as inadequate, noting a lack of specificity regarding assessment & determination of medical necessity of risky and irreversible interventions provided to youth whose identities are still forming. /5
3
984
返信先: さん
The existing Norwegian treatment guidelines for gender-dysphoric youth, based on a 2015 report ”The Right to the Right Sex,” closely mirror WPATH SOC7 “gender-affirming” model. Medical gender affirmation is widely available to youth, with no psychological assessments required. /3
3
956
返信先: さん
NHIB/UKOM notes that the right to medical care does not include the right to experimental treatments. As an experimental intervention, gender transitions will be subject to heightened scrutiny around informed consent, eligibility criteria, and outcomes evaluation./9
2
936
返信先: さん
Sweden becomes the first country to stop the use of the "Dutch protocol" for treating gender dysphoric minors over concerns of medical harm and low certainty of benefit. Other countries (UK, Finland) are also moving away from medicalizing minors. /2
7
924
返信先: さん
The recommendations by the Norwegian Healthcare Investigation Board (NHIB/UKOM) align Norway with the changes among the growing number of European countries (Sweden, Finland, England) which aim to safeguard youth from harm by sharply restricting youth gender transitions. /7
2
931
返信先: さん
Norway's proposed model appears to resemble the model of care outlined in the Cass review. Gender dysphoric youth will receive care for their distress in local primary care settings with multidisciplinary support. Youth gender transitions will be an exception, not the rule. /10
3
928
返信先: さん
The Board also comments on the highly polarized & unbalanced nature of the discussions surrounding care for gender-dysphoric youth, which stifles scientific debate. The Board calls on all parties to treat each other with professionalism, empathy and respect. /11
1
872
返信先: さん
Sweden’s new guidelines emphasize that gender-dysphoric youth will continue to receive care. However, health care for gender dysphoria is no longer reduced to “hormones and surgeries.” The recommendations now call out a key role for psychiatric and psychosocial services. /3
8
843
返信先: さん
As international awareness of the low quality of evidence behind "gender-affirming" hormonal interventions grows, the focus is expected to shift to non-invasive options for ameliorating the distress of gender-dysphoric minors, including psychological treatment and support. /3
9
785
The Royal Australian and New Zealand College of Psychiatrists (RANZCP) released a position statement in which it no longer presents "gender-affirming" hormonal and surgical interventions as the preferred treatment for gender dysphoria in youth. /1
12
736
返信先: さん
The guidelines assert that based on current evidence, the risks of hormonal interventions outweigh the possible benefits. Thus, these interventions (often referred to as "gender-affirming care") will not be available outside of research settings, except as "last-resort." /4
5
723
返信先: さん
SEGM will be analyzing the report in more detail. Currently, our assessment is that the UKOM report is akin to UK's Cass Review in that it makes recommendations for restructuring youth gender services. How Norway's NHS will implement these recommendations remains to be seen. /12
4
709
responded to public concern by extending comment deadline to Feb 2. WHO also clarified that it won't make any recommendations for children & adolescents due to limited evidence regarding long-term outcomes of affirmative care for youth. More below: segm.org/world-health-o
画像
引用
SEGM
@segm_ebm
The World Health Organization has announced the complete panel developing transgender health guidelines in 2024. The panel's unmanaged conflicts of interest will undermine the guidelines' credibility. Public comment deadline (hiv-aids@who.int) is Jan 8. /1 segm.org/world-health-o
52
729
A new peer-reviewed commentary argues that the medical community has a professional responsibility to recognize detransitioners as survivors of iatrogenic harm and provide them with the comprehensive medical and supportive care that they deserve. /1
9
674
The claim that youth whose breasts are removed "can always get them later" contributes to the U.S. gender medicine establishment's promotion of mastectomies for minors 12-13+. However, the surgical technique in masculinizing mastectomy makes reversals unfeasible in most cases. /1
画像
17
670
返信先: さん
The states that the vast majority of gender dysphoric youth need "just the opposite" of hormones & surgery. We call on the to update its guidelines accordingly & articulate the alternative treatment paths including the role of exploratory psychotherapy. /2
5
647
The wave of teens seeking gender transition in the UK continues to grow. According to the most recent data released by #GIDS and its new referral service, after a COVID dip, referrals doubled 2021-22, for a total of 5,000+ referrals. Teen girls continue to dominate this trend. /1
画像
35
616
返信先: さん
Sweden is centralizing its gender care for minors to a few centers for highly specialized care. Individual clinics and private providers will not be allowed to provide "gender-affirming" services. /8
3
632
返信先: さん
Sweden is realigning with the classic “Dutch Protocol” model, where only early childhood-onset gender dysphoria cases will be considered for hormones and surgeries. Those with post-puberty onset of trans identity will not be candidates for hormones/surgeries as minors. /5
8
584
Florida's Boards of Medicine & Osteopathic Medicine voted to no longer allow new medical gender transitions in <18 in general medical settings (but allowed minors already in treatment to proceed with hormones). Poor quality of evidence was the stated basis for the new ban. /1
8
580
The World Health Organization has announced the complete panel developing transgender health guidelines in 2024. The panel's unmanaged conflicts of interest will undermine the guidelines' credibility. Public comment deadline (hiv-aids@who.int) is Jan 8. /1
68
593

Xを使ってみよう

今すぐ登録して、タイムラインをカスタマイズしましょう。
Appleのアカウントで登録
アカウントを作成
アカウントを登録することにより、利用規約プライバシーポリシーCookieの使用を含む)に同意したとみなされます。
トレンドはありません。